This week, trading was started on Tuesday instead of Monday. Stock was bought in Johnson & Johnson, Abbott Laboratories, Baxter, Biocryst Pharmaceuticals, and CytRx with a total of six investments made. Johnson & Johnson stock was bought twice, profiting on the first stock and producing a net loss on the second. Baxter also yielded a net loss, and the other investments were held on to going into week 2.